517 related articles for article (PubMed ID: 23406382)
1. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
Gu L; Guo Z
J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
[TBL] [Abstract][Full Text] [Related]
2. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
Gu L; Guo Z
Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
[TBL] [Abstract][Full Text] [Related]
4. Static and dynamic disorder in Aβ40 fibrils.
Xiao H; Duo L; Zhen J; Wang H; Guo Z
Biochem Biophys Res Commun; 2022 Jun; 610():107-112. PubMed ID: 35461071
[TBL] [Abstract][Full Text] [Related]
5. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
6. Structural origin of polymorphism of Alzheimer's amyloid β-fibrils.
Agopian A; Guo Z
Biochem J; 2012 Oct; 447(1):43-50. PubMed ID: 22823461
[TBL] [Abstract][Full Text] [Related]
7. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Wang L; Eom K; Kwon T
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
[TBL] [Abstract][Full Text] [Related]
8. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
9. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling.
Török M; Milton S; Kayed R; Wu P; McIntire T; Glabe CG; Langen R
J Biol Chem; 2002 Oct; 277(43):40810-5. PubMed ID: 12181315
[TBL] [Abstract][Full Text] [Related]
10. Aβ40 has a subtle effect on Aβ42 protofibril formation, but to a lesser degree than Aβ42 concentration, in Aβ42/Aβ40 mixtures.
Terrill-Usery SE; Colvin BA; Davenport RE; Nichols MR
Arch Biochem Biophys; 2016 May; 597():1-11. PubMed ID: 27013205
[TBL] [Abstract][Full Text] [Related]
11. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
[TBL] [Abstract][Full Text] [Related]
12. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.
Yan Y; Wang C
J Mol Biol; 2006 Dec; 364(5):853-62. PubMed ID: 17046788
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
14. Distinctive contribution of two additional residues in protein aggregation of Aβ42 and Aβ40 isoforms.
Im D; Choi TS
BMB Rep; 2024 Jun; 57(6):263-272. PubMed ID: 38835114
[TBL] [Abstract][Full Text] [Related]
15. EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure.
Jang C; Portugal Barron D; Duo L; Ma C; Seabaugh H; Guo Z
ACS Chem Neurosci; 2024 Jan; 15(1):86-97. PubMed ID: 38109787
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
[TBL] [Abstract][Full Text] [Related]
17. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
18. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.
Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K
Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980
[TBL] [Abstract][Full Text] [Related]
19. Key Residue for Aggregation of Amyloid-β Peptides.
Itoh SG; Yagi-Utsumi M; Kato K; Okumura H
ACS Chem Neurosci; 2022 Nov; 13(22):3139-3151. PubMed ID: 36302506
[TBL] [Abstract][Full Text] [Related]
20. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
